Buspirone hydrochloride structure
|
Common Name | Buspirone hydrochloride | ||
|---|---|---|---|---|
| CAS Number | 33386-08-2 | Molecular Weight | 421.96400 | |
| Density | 1.24g/cm3 | Boiling Point | 613.9ºC at 760mmHg | |
| Molecular Formula | C21H32ClN5O2 | Melting Point | 201.5-202.50C | |
| MSDS | Chinese USA | Flash Point | 325.1ºC | |
| Symbol |
GHS02, GHS06, GHS08 |
Signal Word | Danger | |
Use of Buspirone hydrochlorideBuspirone hydrochloride is an anxiolytic psychotropic drug, is used to treat generalized anxiety disorder (GAD). |
| Name | buspirone hydrochloride |
|---|---|
| Synonym | More Synonyms |
| Description | Buspirone hydrochloride is an anxiolytic psychotropic drug, is used to treat generalized anxiety disorder (GAD). |
|---|---|
| Related Catalog |
| Density | 1.24g/cm3 |
|---|---|
| Boiling Point | 613.9ºC at 760mmHg |
| Melting Point | 201.5-202.50C |
| Molecular Formula | C21H32ClN5O2 |
| Molecular Weight | 421.96400 |
| Flash Point | 325.1ºC |
| Exact Mass | 421.22400 |
| PSA | 69.64000 |
| LogP | 2.83100 |
| InChIKey | RICLFGYGYQXUFH-UHFFFAOYSA-N |
| SMILES | Cl.O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(c2ncccn2)CC1 |
| Storage condition | 2-8°C |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|
| Symbol |
GHS02, GHS06, GHS08 |
|---|---|
| Signal Word | Danger |
| Hazard Statements | H225-H301 + H311 + H331-H370 |
| Precautionary Statements | P210-P260-P280-P301 + P310-P311 |
| Hazard Codes | T:Toxic; |
| Risk Phrases | R25 |
| Safety Phrases | S45 |
| RIDADR | UN 2811 6.1/PG 3 |
| WGK Germany | 3 |
| RTECS | CL9915000 |
| HS Code | 2933990090 |
| HS Code | 2933990090 |
|---|---|
| Summary | 2933990090. heterocyclic compounds with nitrogen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |
|
Is pomegranate juice a potential perpetrator of clinical drug-drug interactions? Review of the in vitro, preclinical and clinical evidence.
Eur. J. Drug Metab. Pharmacokinet. 38(4) , 223-9, (2013) The area of fruit juice-drug interaction has received wide attention with numerous scientific and clinical investigations performed and reported for scores of drugs metabolized by CYP3A4/CYP2C9. While... |
|
|
Premenstrual syndrome: a single-blind study of treatment with buspirone versus fluoxetine.
Arch. Gynecol. Obstet. 287(3) , 469-72, (2013) The premenstrual syndrome (PMS), which causes emotional and physical symptoms, is a common problem in many women in their reproductive age. Many approaches to PMS with controversial results are availa... |
|
|
Two weeks of buspirone protects against posthypoxic ventilatory pauses in the C57BL/6J mouse strain
Respir. Physiol. Neurobiol. 183(1) , 35-40, (2012) The purpose was to determine if 2 weeks of buspirone suppressed post-hypoxic breathing instability and pauses in the C57BL/6J (B6) mouse. Study groups were vehicle (saline, n=8), low-dose (1.5mg/kg, n... |
| 8-[4-(4-pyrimidin-2-ylpiperazin-1-yl)butyl]-8-azaspiro[4.5]decane-7,9-dione,hydrochloride |
| Buspirone Hydrochloride |
| MFCD00078569 |
| N-[4-[4-(2-Pyrimidinyl)-1-piperazinyl]butyl]-8-azaspiro[4.5]decane-7,9-dione hydrochloride |
| EINECS 251-489-4 |